These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21519896)

  • 1. Gadd45α as an upstream signaling molecule of p38 MAPK triggers oxidative stress-induced sFlt-1 and sEng upregulation in preeclampsia.
    Luo X; Yao ZW; Qi HB; Liu DD; Chen GQ; Huang S; Li QS
    Cell Tissue Res; 2011 Jun; 344(3):551-65. PubMed ID: 21519896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress-induced Gadd45α inhibits trophoblast invasion and increases sFlt1/sEng secretions via p38 MAPK involving in the pathology of pre-eclampsia.
    Liu X; Deng Q; Luo X; Chen Y; Shan N; Qi H
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3776-85. PubMed ID: 26809169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia].
    Luo X; Liu DD; Qi HB; Yao ZW
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadd45a stress signaling regulates sFlt-1 expression in preeclampsia.
    Xiong Y; Liebermann DA; Tront JS; Holtzman EJ; Huang Y; Hoffman B; Geifman-Holtzman O
    J Cell Physiol; 2009 Sep; 220(3):632-9. PubMed ID: 19452502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadd45a knockdown alleviates oxidative stress through suppressing the p38 MAPK signaling pathway in the pathogenesis of preeclampsia.
    Li FH; Han N; Wang Y; Xu Q
    Placenta; 2018 May; 65():20-28. PubMed ID: 29908638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
    Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
    Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
    Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uteroplacental arterio-venous difference in soluble VEGFR-1 (sFlt-1), but not in soluble endoglin concentrations in preeclampsia.
    Paasche Roland MC; Lorentzen B; Godang K; Henriksen T
    Placenta; 2012 Mar; 33(3):224-6. PubMed ID: 22264588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
    Gu Y; Lewis DF; Wang Y
    J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia.
    Chedraui P; Lockwood CJ; Schatz F; Buchwalder LF; Schwager G; Guerrero C; Escobar GS; Hidalgo L
    J Matern Fetal Neonatal Med; 2009 Jul; 22(7):565-70. PubMed ID: 19350449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
    Cheng M; He P; Fu J
    J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.
    Reddy A; Suri S; Sargent IL; Redman CW; Muttukrishna S
    PLoS One; 2009; 4(2):e4453. PubMed ID: 19412349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy.
    Salahuddin S; Lee Y; Vadnais M; Sachs BP; Karumanchi SA; Lim KH
    Am J Obstet Gynecol; 2007 Jul; 197(1):28.e1-6. PubMed ID: 17618745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between circulating levels of adipokines and anti-angiogenic factors in women with BMI <30 and a late-onset preeclampsia.
    Eleuterio NM; Palei AC; Rangel Machado JS; Tanus-Santos JE; Cavalli RC; Sandrim VC
    Hypertens Pregnancy; 2014 Feb; 33(1):72-80. PubMed ID: 24380505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.